Panther Healthcare: A Leading Chinese Provider of Smart Minimally Invasive Surgical Solutions with Staplers Exported to Over 60 Countries

The advent of surgery has saved countless lives. However, the significant scarring, higher complication rates, and increased risk of infection associated with traditional open surgery have become major pain points. With continuous advancements in medical care, the trend toward minimally invasive surgical techniques is becoming increasingly pronounced. Minimally invasive surgery is gaining growing favor among both physicians and patients due to its advantages, including reduced trauma, fewer complications, and enhanced safety.

According to data released by the renowned research firm Evaluate MedTech, the global market for minimally invasive surgical devices reached $22.7 billion in 2018. Of this, China’s minimally invasive surgical device market accounted for only 12.3% of the global total, indicating substantial room for growth.

Currently, the industry generally considers the following seven sub-sectors to be the main components of the minimally invasive surgery market: staplers, handheld instruments, energy-based surgical devices, sutures, biomaterials, hernia repair, and tumor ablation. Among them,Surgical staplers account for nearly 50% of China’s minimally invasive surgical device market, with a market size exceeding RMB 10 billion. The industry is experiencing rapid growth, with a projected compound annual growth rate (CAGR) of 20% from 2018 to 2023.

However, shadows persist beneath the sunlight. Beyond handheld instruments and tumor ablation, foreign brands continue to dominate the majority of the market for minimally invasive surgical devices, such as staplers. The market size for laparoscopic staplers in China is approximately RMB 6 billion, with domestic brands holding only a 30% share.

Fortunately, a growing number of domestic companies have sounded the clarion call for a counteroffensive, leveraging their advantages in Chinese-made products and technological innovation to capture the domestic market and expand into overseas markets. A representative company in this regard is Panther Healthcare Medical Equipment Co., Ltd. (hereinafter referred to as “Panther Healthcare”).

According to the introduction, Panther Healthcare is a leading provider of intelligent minimally invasive surgical solutions in China, with full-industry service capabilities encompassing the design, development, production, and customization of surgical products, as well as marketing services tailored to differentiated needs.Currently, Panther Healthcare boasts a diverse product portfolio with over 300 models available for sale, and its products are exported to more than 60 countries and regions, including the United Kingdom, Brazil, and Spain.

“According to statistics from China Customs, among stapler brands in China, Panther Healthcare’s staplers ranked first in export volume for five consecutive years from 2016 to 2020,” Panther Healthcare told VCBeat.

Unlike most companies in the healthcare industry that focus on a single niche segment, Panther Healthcare has established an in-depth strategic presenceStaplers, Handheld Instruments, Energy Surgery, Sutures, Biomaterials, and Hernia Repair.

It is well known that the healthcare industry has high technological and capital barriers, and each sub-sector requires companies to possess different professional capabilities. The reason why Panther Healthcare dares to simultaneously lay out six major fields is because it has sufficient confidence.

Panther Healthcare stated: “The company’s R&D team possesses expertise in multiple fields, including materials science, mechanical engineering, automated control, big data processing, and product design, establishing cross-disciplinary technical barriers. Meanwhile, the company’s core R&D team boasts profound technical accumulation and exceptional capabilities in translating research into practical applications.”As of now, Panther Healthcare has cumulatively obtained approval for more than 200 patents in China, nearly half of which are invention patents. Moreover, two of the company’s projects related to minimally invasive surgery have respectively received the Second Prize of the National Technology Invention Award and the Second Prize of the National Science and Technology Progress Award. Notably, Panther Healthcare is the only enterprise in China’s stapler industry to have won both of these national science and technology awards.”

On the other hand, Panther Healthcare has adopted a forward-looking R&D strategy and established an intelligent minimally invasive product platform. Currently, Panther Healthcare has completed the development of its minimally invasive product platform, evolving from mechanized to semi-automated and finally to intelligent systems, thereby creating a comprehensive portfolio of minimally invasive surgical products.

Leveraging its outstanding R&D and innovation capabilities along with an intelligent minimally invasive product platform, Panther Healthcare has developed a range of innovative minimally invasive surgical instruments. The endoscopic surgical robotics company, in which Panther Healthcare holds a controlling interest, offers optimized configuration solutions tailored to various specialized surgical procedures, making its products widely applicable across multiple clinical departments.

Furthermore, Panther Healthcare has developed and launched the world’s first fully motorized, single-use intelligent electric stapler system for endoscopic surgery. This device automatically identifies firing force feedback, intelligently assesses tissue thickness, and evaluates cartridge compatibility. It also features bidirectional 360-degree stepless rotation, allowing it to remain stable at any angle. Additionally, its chip-enabled cartridge recognition technology is compatible with all chip-equipped cartridges and provides anti-counterfeiting quality assurance. The product received CE certification from the European Union in September 2020 and has since initiated clinical trials in China.

Beyond its product advantages and R&D innovation capabilities, another core strength of Panther Healthcare lies in commercialization.

Panther Healthcare stated: “The company has been deeply engaged in the field of minimally invasive medical devices for many years. Since acting as the distributor for French Peters sutures in 2002, it has established an extensive marketing network. To date, this network covers all 33 provincial-level administrative regions across China, laying a solid foundation for the promotion of its products and services. In overseas markets, the company has established market access and marketing networks in more than 60 countries and regions.”

The reason for such outstanding performance lies in the fact that commercialization capability is ingrained in the DNA of the Panther Healthcare team. Qu Chao, the founder of Panther Healthcare, who has a medical background, has been deeply rooted in the medical device industry for over 30 years, accumulating extensive experience in product selection, quality awareness, and management team building. Meanwhile, the other founder, Liu Qing, boasts 28 years of experience in market sales and corporate management.

In addition, Panther Healthcare’s marketing team comprises many professionals with experience at the world’s leading medical technology companies, boasting extensive market resources. Moreover, some team members are former surgeons, enabling them to better understand the needs of hospital clients. Panther Healthcare stated, “Our marketing team is committed not only to delivering excellent customer service but also to providing diverse recommendations for product development based on user needs.”

Currently, Panther Healthcare collaborates with more than 300 distributors, covering over 1,000 hospitals across China, half of which are Grade III Class A hospitals.

For overseas markets, Panther Healthcare adopts a localization strategy by establishing local marketing and sales teams to gain insights into the needs of local clinicians. It serves overseas hospitals and physicians through professional training and education, as well as intraoperative technical support. Perhaps it is precisely due to its professional services and high-quality products that Panther Healthcare’s overseas market has grown rapidly, with its stapler sales abroad ranking first in China for five consecutive years.

In the future, Panther Healthcare will consolidate its industry-leading position, continuously enhance brand influence, and enrich its product pipeline.

Specifically, Panther Healthcare will continue to optimize and upgrade its stapler products, leveraging the competitive advantages of its intelligent electric staplers to capture a larger market share and consolidate its leading position in China’s stapler industry.

Meanwhile, it has established a product portfolio across three key areas—surgical access, tissue closure, and reconstruction—to offer bundled solutions, with products such as trocars, ultrasonic scalpels, tissue closure clips, specimen retrieval bags, and irrigators being launched sequentially.

Finally, leveraging its strengths in the field of minimally invasive surgery, it is developing surgical robot systems to create comprehensive intelligent solutions for minimally invasive surgery, thereby enhancing brand influence and core competitiveness.